Lantibio Inc.
100 Europa Drive, Suite 421
Chapel Hill
North Carolina
27517
United States
Tel: 919-960-0217
Fax: 919-929-3447
Email: lmolina@lantibio.com
5 articles about Lantibio Inc.
-
Lantibio Inc. and TRB Chemedica Announce Licensing Agreement with Alcon Laboratories, Inc. for US Development and Marketing of Dry Eye Drug
11/6/2007
-
AOP Orphan Pharmaceuticals AG and Lantibio Inc. Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy
3/7/2007
-
Lantibio Inc. And TRB Chemedica Announce Special Protocol Assessment-Endorsed Phase III Trial Initiation Of VISMED(R) For Dry Eye Syndrome
1/17/2007
-
Lantibio Inc. And TRB Chemedica Announce Agreement For US Development And Marketing Of VISMED(R)
1/12/2006
-
AOP Orphan Pharmaceuticals And Lantibio, Inc. Announce A Licensing And Commercialization Agreement For Moli1901 In Cystic Fibrosis
5/27/2004